RFG
ABBV icon

REAP Financial Group’s AbbVie ABBV Stock Holding History

REAP Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Buy
2,018
+22
+1% +$4.73K 0.09% 73
2026
Q1 		$434K Buy
1,996
+243
+14% +$53.9K 0.09% 76
2025
Q4 		$401K Buy
1,753
+332
+23% +$75.6K 0.08% 82
2025
Q3 		$329K Buy
1,421
+276
+24% +$56.2K 0.07% 89
2025
Q2 		$213K Buy
1,145
+497
+77% +$92.4K 0.05% 111
2025
Q1 		$136K Buy
648
+137
+27% +$26.6K 0.03% 133
2024
Q4 		$90.7K Buy
511
+103
+25% +$18.9K 0.02% 164
2024
Q3 		$80.6K Sell
408
-13
-3% -$2.43K 0.02% 172
2024
Q2 		$72.2K Buy
421
+14
+3% +$2.32K 0.02% 170
2024
Q1 		$74.1K Sell
407
-901
-69% -$155K 0.02% 177
2023
Q4 		$203K Buy
+1,308
New +$191K 0.06% 131

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

REAP Financial Group's ABBV Position: Q2 2026 in Review

REAP Financial Group increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $4.73K and bringing the position to 2,018 shares worth $508K. The position accounts for 0.09% of the portfolio, ranked #73.

REAP Financial Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • REAP Financial Group held 2,018 shares of AbbVie worth $508K as of Q2 2026.
  • REAP Financial Group bought 22 AbbVie shares in Q2 2026, an estimated $4.73K.
  • AbbVie made up 0.09% of REAP Financial Group's portfolio in Q2 2026, its #73 holding.
  • REAP Financial Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.